Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
PLoS One ; 7(9): e46293, 2012.
Article in English | MEDLINE | ID: mdl-23029466

ABSTRACT

Besides its role in controlling the morphology of mitochondria, mitofusin-2 has been proposed to tether mitochondria to the endoplasmic reticulum (ER), based largely on light microscopic analysis. In this study we have examined by electron microscopy the organization of ER and mitochondria in cells expressing or not mitofusin-2. Contrary to previous studies, we observed that loss of mitofusin-2 increased ER-mitochondria juxtaposition. These results suggest that mitofusin-2 does not play a critical role in the juxtapostion of ER and mitochondria, and highlight the essential role of ultrastructural analysis to visualize and measure contact between two intracellular compartments.


Subject(s)
Cytoplasm/ultrastructure , Endoplasmic Reticulum/ultrastructure , Fibroblasts/ultrastructure , GTP Phosphohydrolases/genetics , Mitochondria/ultrastructure , Animals , Cells, Cultured , Cytoplasm/metabolism , Embryo, Mammalian , Endoplasmic Reticulum/metabolism , Fibroblasts/metabolism , GTP Phosphohydrolases/deficiency , Gene Knockout Techniques , Genes, Reporter , Green Fluorescent Proteins , Mice , Microscopy, Electron , Microscopy, Fluorescence , Mitochondria/metabolism , Transfection
2.
J Biol Chem ; 287(13): 10134-10144, 2012 Mar 23.
Article in English | MEDLINE | ID: mdl-22298774

ABSTRACT

COPII proteins are essential for exporting most cargo molecules from the endoplasmic reticulum. The membrane-facing surface of the COPII proteins (especially SEC23-SEC24) interacts directly or indirectly with the cargo molecules destined for exit. As we characterized the SEC23A mutations at the SEC31 binding site identified from patients with cranio-lenticulo-sutural dysplasia, we discovered that the SEC23-SEC31 interface can also influence cargo selection. Remarkably, M702V SEC23A does not compromise COPII assembly, vesicle size, and packaging of cargo molecules into COPII vesicles that we have tested but induces accumulation of procollagen in the endoplasmic reticulum when expressed in normal fibroblasts. We observed that M702V SEC23A activates SAR1B GTPase more than wild-type SEC23A when SEC13-SEC31 is present, indicating that M702V SEC23A causes premature dissociation of COPII from the membrane. Our results indicate that a longer stay of COPII proteins on the membrane is required to cargo procollagen than other molecules and suggest that the SEC23-SEC31 interface plays a critical role in capturing various cargo molecules.


Subject(s)
COP-Coated Vesicles/metabolism , Endoplasmic Reticulum/metabolism , Procollagen/metabolism , Vesicular Transport Proteins/metabolism , Amino Acid Substitution , Animals , COP-Coated Vesicles/genetics , Cell Line, Tumor , Endoplasmic Reticulum/genetics , Humans , Mutation, Missense , Procollagen/genetics , Protein Binding , Protein Transport/physiology , Rats , Vesicular Transport Proteins/genetics
3.
Proc Natl Acad Sci U S A ; 107(15): 6876-81, 2010 Apr 13.
Article in English | MEDLINE | ID: mdl-20351264

ABSTRACT

Cortical endoplasmic reticulum (cER) is a permanent feature of yeast cells but occurs transiently in most animal cell types. Ist2p is a transmembrane protein that permanently localizes to the cER in yeast. When Ist2 is expressed in mammalian cells, it induces abundant cER containing Ist2. Ist2 cytoplasmic C-terminal peptide is necessary and sufficient to induce cER. This peptide sequence resembles classic coat protein complex I (COPI) coatomer protein-binding KKXX signals, and indeed the dimerized peptide binds COPI in vitro. Controlled dimerization of this peptide induces cER in cells. RNA interference experiments confirm that coatomer is required for cER induction in vivo, as are microtubules and the microtubule plus-end binding protein EB1. We suggest that Ist2 dimerization triggers coatomer binding and clustering of this protein into domains that traffic at the microtubule growing plus-end to generate the cER beneath the plasma membrane. Sequences similar to the Ist2 lysine-rich tail are found in mammalian STIM proteins that reversibly induce the formation of cER under calcium control.


Subject(s)
COP-Coated Vesicles/chemistry , Endoplasmic Reticulum/metabolism , Intracellular Membranes/metabolism , Animals , COP-Coated Vesicles/metabolism , Cell Membrane/metabolism , Cytoplasm/metabolism , Dimerization , HeLa Cells , Humans , Microscopy, Confocal/methods , Peptides/chemistry , Plasmids/metabolism , Protein Binding , RNA Interference , Rats
4.
Proc Natl Acad Sci U S A ; 106(46): 19358-62, 2009 Nov 17.
Article in English | MEDLINE | ID: mdl-19906989

ABSTRACT

Store-operated calcium entry relies on the formation of a specialized compartment derived from the endoplasmic reticulum (ER) and closely apposed to the plasma membrane. In this study, detailed ultrastructural analysis revealed the existence of three distinct structures derived from conventional ER: precortical ER, cortical ER, and thin cortical ER. Precortical subdomains of the ER enriched in STIM1 can form without contacting the plasma membrane. Upon ER calcium depletion, these subdomains are translocated to the plasma membrane to form cortical ER, which is still connected to the conventional ER. Thin cortical ER, depleted of BiP and deprived of attached ribosomes, may represent a specialized region dedicated to calcium regulation and not engaged in protein translocation and folding. These observations form the basis for future structure-function analysis of cortical ER.


Subject(s)
Calcium/metabolism , Endoplasmic Reticulum/ultrastructure , Membrane Proteins/metabolism , Neoplasm Proteins/metabolism , Calcium Signaling , Cell Membrane/metabolism , Endoplasmic Reticulum/metabolism , HeLa Cells , Humans , Membrane Proteins/genetics , Neoplasm Proteins/genetics , Stromal Interaction Molecule 1
5.
Proc Natl Acad Sci U S A ; 105(16): 6139-44, 2008 Apr 22.
Article in English | MEDLINE | ID: mdl-18413598

ABSTRACT

To determine whether adipocyte storage capacity influences the onset and severity of type 2 diabetes and other components of the metabolic syndrome, we made normal and db/db mice resistant to obesity by overexpressing leptin receptor-b on the aP2-Lepr-b promoter. On a 4% diet, these mice have no phenotype, but on a 60% fat diet, they resist diet-induced obesity because constitutive adipocyte-specific overexpression of Lepr-b prevents obesity via the antilipogenic autocrine/paracrine action of leptin on adipocytes. After 8 months on the same 60% fat diet, body fat of transgenic mice was 70% below WT controls. Cardiac and liver fat was elevated in the transgenics, and their hyperinsulinemia was more marked, suggesting greater insulin resistance. The aP2-Lepr-b transgene also prevented obesity in db/db mice; at 10 weeks of age their body fat was half that of the db/db mice. This lack of obesity was attributable to reduced expression of sterol regulatory element binding protein-1c and its target lipogenic enzymes in adipose tissue and a 6-fold increase in Pref-1 mRNA. Severe diabetes was present in transgenics at 4 weeks of age, 10 weeks before db/db controls. Echocardiographic evidence of cardiomyopathy appeared at 10 weeks, weeks before the db/db mice. Histologically, loss of beta cells and myocardial fibrosis was present in the transgenic group at least 6 weeks before the db/db mice. These results suggest that the expression level of genes that regulate the adipogenic response to overnutrition profoundly influences the age of onset and severity of diet-induced type 2 diabetes and co-morbidities.


Subject(s)
Adipogenesis/genetics , Diabetes Mellitus, Type 2/genetics , Genetic Predisposition to Disease/genetics , Metabolic Syndrome/genetics , Obesity/genetics , Receptors, Leptin/genetics , Adipocytes/metabolism , Adipose Tissue/metabolism , Animals , Calcium-Binding Proteins , Cardiomyopathies/genetics , Cardiomyopathies/pathology , Glucagon/analysis , Glucagon/metabolism , Insulin/analysis , Insulin/metabolism , Intercellular Signaling Peptides and Proteins/genetics , Intercellular Signaling Peptides and Proteins/metabolism , Mice , Mice, Transgenic , Pancreas/chemistry , Pancreas/metabolism , Promoter Regions, Genetic , RNA, Messenger/analysis , RNA, Messenger/metabolism , Sterol Regulatory Element Binding Protein 1/genetics , Sterol Regulatory Element Binding Protein 1/metabolism , Transgenes
6.
Dev Cell ; 13(5): 623-634, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17981132

ABSTRACT

Proteins trafficking through the secretory pathway must first exit the endoplasmic reticulum (ER) through membrane vesicles created and regulated by the COPII coat protein complex. Cranio-lenticulo-sutural dysplasia (CLSD) was recently shown to be caused by a missense mutation in SEC23A, a gene encoding one of two paralogous COPII coat proteins. We now elucidate the molecular mechanism underlying this disease. In vitro assays reveal that the mutant form of SEC23A poorly recruits the Sec13-Sec31 complex, inhibiting vesicle formation. Surprisingly, this effect is modulated by the Sar1 GTPase paralog used in the reaction, indicating distinct affinities of the two human Sar1 paralogs for the Sec13-Sec31 complex. Patient cells accumulate numerous tubular cargo-containing ER exit sites devoid of observable membrane coat, likely representing an intermediate step in COPII vesicle formation. Our results indicate that the Sar1-Sec23-Sec24 prebudding complex is sufficient to form cargo-containing tubules in vivo, whereas the Sec13-Sec31 complex is required for membrane fission.


Subject(s)
COP-Coated Vesicles/physiology , Craniofacial Abnormalities/genetics , Vesicular Transport Proteins/metabolism , Amino Acid Sequence , Carrier Proteins/metabolism , Cell Membrane/metabolism , Cells, Cultured , Craniofacial Abnormalities/metabolism , Craniofacial Abnormalities/pathology , Endoplasmic Reticulum/physiology , Fibroblasts/physiology , Humans , Membrane Fusion , Models, Molecular , Molecular Sequence Data , Monomeric GTP-Binding Proteins/metabolism , Mutation , Osteoblasts/physiology , Protein Transport , Vesicular Transport Proteins/genetics
7.
Diabetes ; 56(9): 2295-301, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17563069

ABSTRACT

The objective of this study was to determine whether the late failure of beta-cells in islets transplanted via the portal vein is caused by excess insulin-stimulated lipogenesis and lipotoxicity and, if so, whether the damage can be prevented by reducing lipogenesis surrounding the islets. Based on the premise that high portal vein levels of nutrients and incretins would stimulate hyperinsulinemia, thereby inducing intense lipogenesis in nearby hepatocytes, normal islets were transplanted into livers of syngeneic streptozotocin-induced diabetic recipients. Hydrolysis of the surrounding fat would flood the islet grafts with fatty acids that could damage and destroy the beta-cells. Reducing lipogenesis by leptin or caloric restriction should prevent or reduce the destruction. After a rise after transplantation, insulin levels gradually declined and hyperglycemia increased. Four weeks after transplantation mRNA of the lipogenic transcription factor, sterol regulatory element-binding protein-1c (SREBP-1c) and its lipogenic target enzymes were elevated in livers of these recipients, as was triacylglycerol content. Positive oil red O staining for lipids and immunostaining for SREBP-1 were observed in hepatocytes surrounding islets with damaged beta-cells. Leptin-induced lipopenia prevented and caloric restriction reduced steatosis, hyperglycemia, and apoptotic beta-cell destruction. Excessive SREBP-1c-mediated lipogenesis, induced in hepatocytes by insulin hypersecretion, is followed by beta-cell destruction in the grafts and reappearance of diabetes. Graft failure is prevented by blocking lipogenesis. The results suggest that strict antilipogenic intervention might improve outcomes after human islet transplantation.


Subject(s)
Diabetes Mellitus, Experimental/surgery , Insulin-Secreting Cells/metabolism , Islets of Langerhans Transplantation/pathology , Islets of Langerhans Transplantation/physiology , Leptin/therapeutic use , Animals , Graft Survival/physiology , Insulin/metabolism , Insulin Secretion , Lipids/physiology , Liver/cytology , Liver/metabolism , Rats , Transplantation, Isogeneic
8.
J Biol Chem ; 281(52): 40283-91, 2006 Dec 29.
Article in English | MEDLINE | ID: mdl-17038325

ABSTRACT

Intense hyperleptinemia completely depletes adipocyte fat of normal rats within 14 days. To determine the mechanism, epididymal fat pads from normal wild-type (+/+) and obese (fa/fa) Zucker Diabetic Fatty (ZDF) donor rats were transplanted into normal +/+ and fa/fa ZDF recipients. Hyperleptinemia induced by adenovirus-leptin administration depleted all fat from native fat pads and from fat transplants from +/+ donors but not from transplants from ZDF(fa/fa) donors with defective leptin receptors. In both native and transplanted +/+ fat pads, large numbers of mitochondria were apparent, and genes involved in fatty acid oxidation were up-regulated. However, +/+ fat pads transplanted into fa/fa recipients did not respond to hyperleptinemia, suggesting lack of an essential leptin-stimulated cohormone(s). In +/+ but not in fa/fa rats, plasma catecholamine levels rose, and both P-STAT3 and P-CREB increased in adipose tissue, suggesting that both direct and indirect (hypothalamic) leptin receptor-mediated actions of hyperleptinemia are involved in depletion of adipocyte fat.


Subject(s)
Adipose Tissue, White/metabolism , Fatty Acids/antagonists & inhibitors , Hypothalamus/metabolism , Leptin/physiology , Obesity/genetics , Obesity/physiopathology , Obesity/therapy , Thinness/genetics , Adipose Tissue, White/transplantation , Animals , Catecholamines/blood , Catecholamines/physiology , Fatty Acids/blood , Fatty Acids/genetics , Hypothalamus/physiology , Hypothalamus/physiopathology , Leptin/antagonists & inhibitors , Leptin/blood , Male , Mice , Obesity/blood , Oxidation-Reduction , Rats , Rats, Zucker , Receptors, Cell Surface/deficiency , Receptors, Cell Surface/genetics , Receptors, Cell Surface/physiology , Receptors, Leptin , STAT3 Transcription Factor/metabolism , STAT3 Transcription Factor/physiology , Solubility , Thinness/blood , Thinness/physiopathology
9.
Nat Genet ; 38(10): 1192-7, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16980979

ABSTRACT

Cranio-lenticulo-sutural dysplasia (CLSD) is an autosomal recessive syndrome characterized by late-closing fontanels, sutural cataracts, facial dysmorphisms and skeletal defects mapped to chromosome 14q13-q21 (ref. 1). Here we show, using a positional cloning approach, that an F382L amino acid substitution in SEC23A segregates with this syndrome. SEC23A is an essential component of the COPII-coated vesicles that transport secretory proteins from the endoplasmic reticulum to the Golgi complex. Electron microscopy and immunofluorescence show that there is gross dilatation of the endoplasmic reticulum in fibroblasts from individuals affected with CLSD. These cells also exhibit cytoplasmic mislocalization of SEC31. Cell-free vesicle budding assays show that the F382L substitution results in loss of SEC23A function. A phenotype reminiscent of CLSD is observed in zebrafish embryos injected with sec23a-blocking morpholinos. Our observations suggest that disrupted endoplasmic reticulum export of the secretory proteins required for normal morphogenesis accounts for CLSD.


Subject(s)
Abnormalities, Multiple/genetics , Endoplasmic Reticulum/metabolism , Golgi Apparatus/metabolism , Mutation , Vesicular Transport Proteins/genetics , Vesicular Transport Proteins/metabolism , Amino Acid Sequence , Animals , Cataract/genetics , Disease Models, Animal , Embryo, Nonmammalian , Facial Bones/abnormalities , Female , Humans , Male , Molecular Sequence Data , Pedigree , Protein Transport/genetics , Zebrafish/embryology , Zebrafish/genetics , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism
10.
Endocrinology ; 147(7): 3398-407, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16601139

ABSTRACT

Chronic free fatty acid (FFA) exposure induces pancreatic beta-cell death, which may contribute to the development of type 2 diabetes. The mechanisms involved in FFA-induced cell death are not completely understood. Here we have investigated the effect of FFA on endoplasmic reticulum (ER) stress pathways in INS-1 pancreatic beta-cells. INS-1 cells exposed to palmitate for 16-24 h under serum-free conditions showed marked apoptosis and increased protein levels of phosphorylated eukaryotic translation initiation factor 2alpha (eIF2alpha), activating transcription factor 4 (ATF4), X box-binding protein 1 (XBP-1), and C/EBP homologous transcription factor (CHOP) compared with control cells. The CHOP transcription factor has been implicated in mediating ER stress-induced apoptosis. Unexpectedly, the levels of the ER chaperone proteins Grp78/BiP and PDI were not affected by palmitate treatment, suggesting that the cell protective aspects of the unfolded protein response (UPR) are not up-regulated by palmitate. Palmitate-treated cells had markedly altered distribution of ER chaperones and altered ER morphology, suggesting that accumulation of misfolded proteins might trigger the ER stress response. In contrast, oleate treatment did not significantly induce the UPR pathways, nor was it as detrimental to INS-1 beta-cells. The results suggest that activation of the UPR may significantly contribute to palmitate- but not oleate-induced pancreatic beta-cell death.


Subject(s)
Apoptosis , Endoplasmic Reticulum/metabolism , Insulin-Secreting Cells/metabolism , Oleic Acid/pharmacology , Palmitic Acid/pharmacology , Animals , Calcium/metabolism , Cell Line , Cell Nucleus/metabolism , Fatty Acids, Nonesterified/metabolism , Insulin-Secreting Cells/pathology , Islets of Langerhans/pathology , Microscopy, Electron , Phosphorylation , Rats
11.
Proc Natl Acad Sci U S A ; 102(50): 18011-6, 2005 Dec 13.
Article in English | MEDLINE | ID: mdl-16326804

ABSTRACT

Hyperleptinemia rapidly depletes adipocyte fat in lean rats, whereas comparable hyperleptinemia produced by adipocytes in diet-induced obesity does not, implying a leptinergic blockade in adipocytes during overnutrition. Indeed, activated STAT-3 in white adipose tissue (WAT) of normal rats was less on a 60% high fat diet (HFD) than on 4% fat, despite a 10-fold higher plasma leptin. In 6 days of a HFD, mRNA of the postreceptor leptin inhibitor, suppressor of cytokine signaling-3, increased 22-fold in WAT, while leptin receptor (Lepr-b) mRNA gradually disappeared, implying leptinergic blockade at both postreceptor and receptor levels. Adipocyte-specific Lepr-b overexpression of a Lepr-b transgene completely prevented the adipocyte hypertrophy and hyperplasia and the increase in body fat induced in wild-type mice by HFD. Activated STAT-3 and AMP-activated protein kinase (AMPK), and the mRNA of lipooxidative enzymes, peroxisome proliferator-activated receptor-gamma-coactivator-1alpha, and uncoupling protein-1 and -2 were increased in WAT. Body temperature was elevated in the transgenic mice, suggesting uncoupled fatty acid oxidation of surplus fatty acids. In conclusion, storage of surplus calories in WAT and the development of diet-induced obesity require the blockade of a latent leptin-stimulated caloric sump in white adipocytes.


Subject(s)
Adipocytes/metabolism , Gene Expression Regulation/drug effects , Leptin/metabolism , Lipid Metabolism , Obesity/metabolism , Paracrine Communication/drug effects , Adenylate Kinase/metabolism , Adipocytes/cytology , Adipocytes/drug effects , Animals , Carrier Proteins/metabolism , Dietary Fats/pharmacology , Enzyme-Linked Immunosorbent Assay , Immunoblotting , Ion Channels , Leptin/blood , Male , Membrane Proteins/metabolism , Membrane Transport Proteins/metabolism , Mice , Mice, Transgenic , Mitochondrial Proteins/metabolism , Paracrine Communication/physiology , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Rats , Rats, Sprague-Dawley , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Receptors, Leptin , Reverse Transcriptase Polymerase Chain Reaction , STAT3 Transcription Factor/metabolism , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins/metabolism , Time Factors , Trans-Activators/metabolism , Transcription Factors , Transgenes/genetics , Uncoupling Protein 1 , Uncoupling Protein 2
12.
Proc Natl Acad Sci U S A ; 102(41): 14647-52, 2005 Oct 11.
Article in English | MEDLINE | ID: mdl-16199514

ABSTRACT

Localization of a membrane protein in a subcellular compartment can be achieved by its retention in the compartment or by its continuous transport toward this compartment. Previous results have suggested that specific enzymes are localized in the Golgi apparatus at least in part by selective retention and exclusion from transport vesicles. However, the function of some Golgi SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins is not compatible with their exclusion from transport vesicles. To help understand the mechanism accounting for the localization of SNARE proteins in the Golgi apparatus, we analyzed their lateral distribution in the Golgi cisternae and their incorporation into transport vesicles. According to our results, all SNARE proteins are efficiently incorporated into transport vesicles, indicating that the localization of SNARE proteins in the Golgi apparatus is not based on a static retention mechanism. Detailed analysis suggested that incorporation into transport vesicles was more efficient for SNARE proteins restricted to the cis face of the Golgi as compared with SNAREs present at the trans face. Furthermore, overexpression of a cis-Golgi SNARE protein altered concomitantly its incorporation in transport vesicles and its intra-Golgi localization. These observations suggest that, contrary to resident Golgi enzymes, SNARE proteins are localized in the Golgi apparatus as the result of a dynamic transport equilibrium.


Subject(s)
Golgi Apparatus/metabolism , SNARE Proteins/metabolism , Transport Vesicles/metabolism , Animals , Biological Transport/physiology , Blotting, Western , CHO Cells , Cricetinae , Cricetulus , Fluorescent Antibody Technique , Golgi Apparatus/ultrastructure , Microscopy, Electron
13.
Cell ; 122(4): 605-17, 2005 Aug 26.
Article in English | MEDLINE | ID: mdl-16122427

ABSTRACT

Secretory proteins traffic from the ER to the Golgi via COPII-coated transport vesicles. The five core COPII proteins (Sar1p, Sec23/24p, and Sec13/31p) act in concert to capture cargo proteins and sculpt the ER membrane into vesicles of defined geometry. The molecular details of how the coat proteins deform the lipid bilayer into vesicles are not known. Here we show that the small GTPase Sar1p directly initiates membrane curvature during vesicle biogenesis. Upon GTP binding by Sar1p, membrane insertion of the N-terminal amphipathic alpha helix deforms synthetic liposomes into narrow tubules. Replacement of bulky hydrophobic residues in the alpha helix with alanine yields Sar1p mutants that are unable to generate highly curved membranes and are defective in vesicle formation from native ER membranes despite normal recruitment of coat and cargo proteins. Thus, the initiation of vesicle budding by Sar1p couples the generation of membrane curvature with coat-protein assembly and cargo capture.


Subject(s)
COP-Coated Vesicles/metabolism , Endoplasmic Reticulum/metabolism , Intracellular Membranes/metabolism , Monomeric GTP-Binding Proteins/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Binding Sites/physiology , COP-Coated Vesicles/ultrastructure , Endoplasmic Reticulum/ultrastructure , Golgi Apparatus/metabolism , Guanosine Triphosphate/metabolism , Intracellular Membranes/ultrastructure , Lipid Bilayers/metabolism , Microscopy, Electron, Transmission , Monomeric GTP-Binding Proteins/chemistry , Monomeric GTP-Binding Proteins/genetics , Mutation/physiology , Protein Structure, Secondary/physiology , Protein Transport/physiology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/ultrastructure , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/genetics , Vesicular Transport Proteins
14.
J Biol Chem ; 280(9): 7758-68, 2005 Mar 04.
Article in English | MEDLINE | ID: mdl-15623526

ABSTRACT

Mutant forms of presenilin (PS) 1 and 2 and amyloid precursor protein (APP) lead to familial Alzheimer's disease. Several reports indicate that PS may modulate APP export from the endoplasmic reticulum (ER). To develop a test of this possibility, we reconstituted the capture of APP and PS1 in COPII (coat protein complex II) vesicles formed from ER membranes in permeabilized cultured cells. The recombinant forms of mammalian COPII proteins were active in a reaction that measures coat subunit assembly and coated vesicle budding on chemically defined synthetic liposomes. However, the recombinant COPII proteins were not active in cargo capture and vesicle budding from microsomal membranes. In contrast, rat liver cytosol was active in stimulating the sorting and packaging of APP, PS1, and p58 (an itinerant ER to Golgi marker protein) into transport vesicles from donor ER membranes. Budding was stimulated in dilute cytosol by the addition of recombinant COPII proteins. Fractionation of the cytosol suggested one or more additional proteins other than the COPII subunits may be essential for cargo selection or vesicle formation from the mammalian ER membrane. The recombinant Sec24C specifically recognized the APP C-terminal region for packaging. Titration of Sarla distinguished the packaging requirements of APP and PS1. Furthermore, APP packaging was not affected by deletion of PS1 or PS1 and 2, suggesting APP and PS1 trafficking from the ER are normally uncoupled.


Subject(s)
Amyloid beta-Protein Precursor/chemistry , Amyloid beta-Protein Precursor/metabolism , COP-Coated Vesicles/chemistry , Membrane Proteins/chemistry , Adenosine Triphosphate/chemistry , Animals , CHO Cells , Cricetinae , Cytosol/metabolism , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Endoplasmic Reticulum/metabolism , Fibroblasts/metabolism , Glutathione Transferase/metabolism , Humans , Intracellular Membranes/metabolism , Liposomes/chemistry , Liposomes/metabolism , Liver/metabolism , Membrane Proteins/metabolism , Microsomes, Liver/metabolism , Plasmids/metabolism , Presenilin-1 , Protein Structure, Tertiary , Rats , Recombinant Proteins/chemistry , Subcellular Fractions/metabolism
15.
Endocrine ; 24(1): 83-91, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15249707

ABSTRACT

Thioacetamide (0.01-1.3 mM) fails to exert any significant immediate effect upon insulin release from rat isolated islets. However, when administered (4 micromol/g body wt) intraperitoneally 24 h before sacrifice, it reduced food intake and body weight and affected the secretory response of isolated islets to several secretagogues, despite unaltered insulin content of such islets. This coincided with a decrease in D-[U-14C]glucose oxidation, total islet calcium content and the ionized calcium content of secretory granules in islet B-cells, and changes in both 133Ba and 45Ca net uptake. Likewise, in islets prepared from thioacetamide-injected rats and prelabeled with 45Ca before perifusion, the cationic and insulin secretory responses to D-glucose or gliclazide, but not to the association of Ba2+ and theophylline in the absence of extracellular Ca2+, often differed from that otherwise found in islets prepared from control rats. These findings are interpreted as indicative of an impaired capacity of Ca2+ sequestration by intracellular organelles in the islet B-cells of thioacetamide-treated rats.


Subject(s)
Calcium/metabolism , Insulin/metabolism , Islets of Langerhans/drug effects , Thioacetamide/pharmacology , Animals , Body Weight/drug effects , Eating/drug effects , Female , Glucose/metabolism , Injections, Intraperitoneal , Insulin/blood , Insulin Secretion , Islets of Langerhans/metabolism , Microscopy, Immunoelectron , Perfusion , Radioisotopes , Rats
16.
Proc Natl Acad Sci U S A ; 101(7): 2058-63, 2004 Feb 17.
Article in English | MEDLINE | ID: mdl-14769942

ABSTRACT

Adenovirus-induced hyperleptinemia rapidly depletes body fat in normal rats without increasing free fatty acids and ketogenesis, implying that fat-storing adipocytes are oxidizing the fat. To analyze the ultrastructural changes of adipocytes accompanying this functional transformation, we examined the fat tissue by electron microscopy. After 14 days of hyperleptinemia, adipocytes had become shrunken, fatless, and encased in a thick basement-membrane-like matrix. They were crowded with mitochondria that were much smaller than those of brown adipocytes. Their gene expression profile revealed striking up-regulation of peroxisome proliferator-activated receptor gamma coactivator 1alpha (an up-regulator of mitochondrial biogenesis not normally expressed in white fat), increased uncoupling proteins-1 and -2, and down-regulation of lipogenic enzymes. Phosphorylation of both acetyl CoA carboxylase and AMP-activated protein kinase was increased, thus explaining the increase in fatty acid oxidation. The ability to transform adipocytes into unique fat-burning cells may suggest novel therapeutic strategies for obesity.


Subject(s)
Adipocytes/metabolism , Lipid Metabolism , Oxidants/metabolism , Adenoviridae/genetics , Adipocytes/chemistry , Adipocytes/enzymology , Adipocytes/pathology , Adipose Tissue/enzymology , Adipose Tissue/metabolism , Adipose Tissue/pathology , Animals , Biomarkers , Gene Expression Regulation , Hyperlipidemias/enzymology , Hyperlipidemias/genetics , Hyperlipidemias/metabolism , Hyperlipidemias/pathology , Leptin/genetics , Leptin/metabolism , Mitochondria/metabolism , Oxidation-Reduction , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Zucker , Transcription Factors/genetics
17.
Mol Biol Cell ; 15(4): 1506-18, 2004 Apr.
Article in English | MEDLINE | ID: mdl-14742712

ABSTRACT

Genetic and biochemical evidence has established that a SNARE complex consisting of syntaxin 5 (Sed5)-mYkt6 (Ykt6)-GOS28 (Gos1)-GS15 (Sft1) is required for transport of proteins across the Golgi stack in animals (yeast). We have utilized quantitative immunogold labeling to establish the cis-trans distribution of the v-SNARE GS15 and the t-SNARE subunits GOS28 and syntaxin 5. Whereas the distribution of the t-SNARE is nearly even across the Golgi stack from the cis to the trans side, the v-SNARE GS15 is present in a gradient of increasing concentration toward the trans face of the stack. This contrasts with a second distinct SNARE complex, also required for intra-Golgi transport, consisting of syntaxin 5 (Sed5)-membrin (Bos1)-ERS24 (Sec22)-rBet1 (Bet1), whose v-(rBet1) and t-SNARE subunits (membrin and ERS24), progressively decrease in concentration toward the trans face. Transport within the stack therefore appears to utilize countercurrent gradients of two Golgi SNAREpins and may involve a mechanism akin to homotypic fusion.


Subject(s)
Golgi Apparatus/metabolism , Vesicular Transport Proteins/chemistry , Animals , Biological Transport , Carrier Proteins/metabolism , Cell Line , Cell Membrane/metabolism , Cell-Free System , Dose-Response Relationship, Drug , HeLa Cells , Humans , Immunohistochemistry , Kidney/metabolism , Membrane Proteins/metabolism , Microscopy, Electron , Microscopy, Fluorescence , Models, Biological , Precipitin Tests , Qa-SNARE Proteins , Qb-SNARE Proteins , Qc-SNARE Proteins , R-SNARE Proteins , Rats , SNARE Proteins , Vesicular Transport Proteins/metabolism
18.
J Cell Biol ; 164(1): 79-88, 2004 Jan 05.
Article in English | MEDLINE | ID: mdl-14699088

ABSTRACT

A new functional class of SNAREs, designated inhibitory SNAREs (i-SNAREs), is described here. An i-SNARE inhibits fusion by substituting for or binding to a subunit of a fusogenic SNAREpin to form a nonfusogenic complex. Golgi-localized SNAREs were tested for i-SNARE activity by adding them as a fifth SNARE together with four other SNAREs that mediate Golgi fusion reactions. A striking pattern emerges in which certain subunits of the cis-Golgi SNAREpin function as i-SNAREs that inhibit fusion mediated by the trans-Golgi SNAREpin, and vice versa. Although the opposing distributions of the cis- and trans-Golgi SNAREs themselves could provide for a countercurrent fusion pattern in the Golgi stack, the gradients involved would be strongly sharpened by the complementary countercurrent distributions of the i-SNAREs.


Subject(s)
Golgi Apparatus/metabolism , Intracellular Membranes/metabolism , Membrane Fusion/physiology , Membrane Proteins/metabolism , Vesicular Transport Proteins , Binding Sites/physiology , Golgi Apparatus/ultrastructure , Intracellular Membranes/chemistry , Intracellular Membranes/ultrastructure , Membrane Proteins/classification , Membrane Proteins/genetics , Protein Binding/physiology , Protein Subunits/metabolism , Protein Transport/physiology , SNARE Proteins , Signal Transduction/physiology , trans-Golgi Network/physiology
19.
Proc Natl Acad Sci U S A ; 100(8): 4586-91, 2003 Apr 15.
Article in English | MEDLINE | ID: mdl-12663859

ABSTRACT

Yeast endoplasmic reticulum (ER) vesicle protein Erv46p is a novel membrane protein involved in transport through the early secretory pathway. Investigation of mammalian Erv46 (mErv46) reveals that it is broadly expressed in tissues and protein-secreting cells. By immunofluorescence microscopy, mErv46 displays a crescent-shaped perinuclear staining pattern that is characteristic of the Golgi complex. Quantitative immunoelectron microscopy indicates that mErv46 is restricted to the cis face of the Golgi apparatus and to vesicular tubular structures between the transitional ER and cis-Golgi. Minor amounts of mErv46 reside in ER membranes and later Golgi cisternae. On Brefeldin A treatment, mErv46 redistributes to punctate structures that costain for ERGIC53. Depletion of mErv46 protein by RNA interference caused no apparent structural changes in the intermediate compartment or Golgi complex. These findings place mErv46 in a group of itinerant proteins that cycle between the ER and Golgi compartments such as ERGIC53 and the p24 proteins.


Subject(s)
Endoplasmic Reticulum/metabolism , Golgi Apparatus/metabolism , Membrane Proteins/metabolism , Animals , Base Sequence , Biological Transport, Active/drug effects , Brefeldin A/pharmacology , COS Cells , Cell Line , DNA, Complementary/genetics , HeLa Cells , Humans , Mannose-Binding Lectins/metabolism , Membrane Proteins/genetics , Mice , Microscopy, Immunoelectron , RNA Interference
20.
Proc Natl Acad Sci U S A ; 99(16): 10299-304, 2002 Aug 06.
Article in English | MEDLINE | ID: mdl-12136131

ABSTRACT

The neuroendocrine processing endoproteases PC2 and PC1/3 are expressed in the beta cells of the islets of Langerhans and participate in the processing of proinsulin to insulin and C-peptide. We have previously shown that disruption of PC2 (SPC2) expression significantly impairs proinsulin processing. Here we report that disruption of the expression of PC1/3 (SPC3) produces a much more severe block in proinsulin conversion. In nulls, pancreatic and circulating proinsulin-like components comprise 87% and 91%, respectively, of total insulin-related immunoreactivity. Heterozygotes also show a more than 2-fold elevation in proinsulin levels to approximately 12%. Immunocytochemical and ultrastructural studies of the beta cells reveal the nearly complete absence of mature insulin immunoreactivity and its replacement by that of proinsulin in abundant immature-appearing secretory granules. In contrast, alpha cell morphology and glucagon processing are normal, and there is also no defect in somatostatin-14 generation. Pulse-chase labeling studies confirm the existence of a major block in proinsulin processing in PC1/3 nulls with prolongation of half-times of conversion by 7- and 10-fold for proinsulins I and II, respectively. Lack of PC1/3 also results in increased levels of des-64,65 proinsulin intermediates generated by PC2, in contrast to PC2 nulls, in which des- 31,32 proinsulin intermediates predominate. These results confirm that PC1/3 plays a major role in processing proinsulin, but that its coordinated action with PC2 is necessary for the most efficient and complete processing of this prohormone.


Subject(s)
Aspartic Acid Endopeptidases/metabolism , Insulin/biosynthesis , Islets of Langerhans/metabolism , Peptide Fragments/metabolism , Proinsulin/metabolism , Proprotein Convertase 1 , Protein Processing, Post-Translational , Animals , Aspartic Acid Endopeptidases/genetics , Islets of Langerhans/cytology , Mice , Mice, Knockout , Proprotein Convertases
SELECTION OF CITATIONS
SEARCH DETAIL
...